company background image
BHTG

BioHiTech GlobalNasdaqCM:BHTG Stock Report

Market Cap

US$38.3m

7D

4.8%

1Y

7.3%

Updated

19 Oct, 2021

Data

Company Financials +
BHTG fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health1/6
Dividends0/6

BHTG Overview

BioHiTech Global, Inc., through its subsidiaries, provides technological, biological, and mechanical engineering solutions of organic and municipal waste worldwide.

BioHiTech Global Competitors

Ever Harvest International Group

OTCPK:TLGN

US$625.8k

Price History & Performance

Summary of all time highs, changes and price drops for BioHiTech Global
Historical stock prices
Current Share PriceUS$1.32
52 Week HighUS$1.10
52 Week LowUS$4.03
Beta1.24
1 Month Change-10.20%
3 Month Change-6.38%
1 Year Change7.32%
3 Year Change-54.64%
5 Year Change-58.75%
Change since IPO-70.67%

Recent News & Updates

Jul 07
BioHiTech Global, Inc. (NASDAQ:BHTG) Shares Could Be 48% Below Their Intrinsic Value Estimate

BioHiTech Global, Inc. (NASDAQ:BHTG) Shares Could Be 48% Below Their Intrinsic Value Estimate

How far off is BioHiTech Global, Inc. ( NASDAQ:BHTG ) from its intrinsic value? Using the most recent financial data...

Jun 09

BioHiTech Global signs project management pact with Lone Cypress Energy

BioHiTech Global (BHTG) has entered into a project management services agreement with Lone Cypress Energy Services to evaluate and develop new High-Efficiency Biological Treatment projects.The two companies will also explore additional uses of solid recovered fuel and other potential fuels that could be developed.Under the pact, Lone Cypress will take a lead role in environmental permitting and regulatory compliance services related to the development of additional patented HEBioT facilities and in the renewable energy business sector.Further, both parties are also

Shareholder Returns

BHTGUS Commercial ServicesUS Market
7D4.8%3.3%4.0%
1Y7.3%27.1%30.5%

Return vs Industry: BHTG underperformed the US Commercial Services industry which returned 26.9% over the past year.

Return vs Market: BHTG underperformed the US Market which returned 30% over the past year.

Price Volatility

Is BHTG's price volatile compared to industry and market?
BHTG volatility
BHTG Beta1.24
Industry Beta1.03
Market Beta1

Stable Share Price: BHTG is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: BHTG's weekly volatility has decreased from 13% to 7% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a42Tony Fullerhttps://www.biohitech.com

BioHiTech Global, Inc., through its subsidiaries, provides technological, biological, and mechanical engineering solutions of organic and municipal waste worldwide. Its suite of technologies includes on-site biological processing equipment for food waste, patented processing facilities for the conversion of municipal solid waste into renewable fuel, and proprietary real-time data analytics tools to reduce food waste generation. The company also markets Revolution Series Digesters, an aerobic digestion technology solution for the disposal of food waste at the point of generation; and High Efficiency Biological Treatment Resource Recovery Technology to process waste at the municipal or enterprise level.

BioHiTech Global Fundamentals Summary

How do BioHiTech Global's earnings and revenue compare to its market cap?
BHTG fundamental statistics
Market CapUS$38.32m
Earnings (TTM)-US$11.10m
Revenue (TTM)US$9.74m

3.9x

P/S Ratio

-3.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BHTG income statement (TTM)
RevenueUS$9.74m
Cost of RevenueUS$8.41m
Gross ProfitUS$1.33m
ExpensesUS$12.43m
Earnings-US$11.10m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.38
Gross Margin13.63%
Net Profit Margin-113.93%
Debt/Equity Ratio535.2%

How did BHTG perform over the long term?

See historical performance and comparison

Valuation

Is BioHiTech Global undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: BHTG ($1.32) is trading below our estimate of fair value ($3.21)

Significantly Below Fair Value: BHTG is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: BHTG is unprofitable, so we can't compare its PE Ratio to the US Commercial Services industry average.

PE vs Market: BHTG is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BHTG's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BHTG is overvalued based on its PB Ratio (57x) compared to the US Commercial Services industry average (2.5x).


Future Growth

How is BioHiTech Global forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

50.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BHTG is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: BHTG is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: BHTG is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: BHTG's revenue (31% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: BHTG's revenue (31% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BHTG's Return on Equity is forecast to be high in 3 years time


Past Performance

How has BioHiTech Global performed over the past 5 years?

-8.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BHTG is currently unprofitable.

Growing Profit Margin: BHTG is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: BHTG is unprofitable, and losses have increased over the past 5 years at a rate of 8.2% per year.

Accelerating Growth: Unable to compare BHTG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BHTG is unprofitable, making it difficult to compare its past year earnings growth to the Commercial Services industry (33.8%).


Return on Equity

High ROE: BHTG has a negative Return on Equity (-190.67%), as it is currently unprofitable.


Financial Health

How is BioHiTech Global's financial position?


Financial Position Analysis

Short Term Liabilities: BHTG's short term assets ($9.6M) do not cover its short term liabilities ($18.7M).

Long Term Liabilities: BHTG's short term assets ($9.6M) do not cover its long term liabilities ($32.4M).


Debt to Equity History and Analysis

Debt Level: BHTG's debt to equity ratio (535.2%) is considered high.

Reducing Debt: BHTG had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BHTG has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if BHTG has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is BioHiTech Global current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate BHTG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BHTG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if BHTG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BHTG's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BHTG's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.8yrs

Average management tenure


CEO

Tony Fuller (63 yo)

0.92

Tenure

US$162,201

Compensation

Mr. Anthony Fuller, also known as Tony, has been the Chief Executive Officer of BioHiTech Global, Inc. since November 5, 2020 and served as its Chief Administrative Officer since March 2020 until November...


CEO Compensation Analysis

Compensation vs Market: Tony's total compensation ($USD162.20K) is below average for companies of similar size in the US market ($USD545.22K).

Compensation vs Earnings: Tony's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: BHTG's management team is considered experienced (3.8 years average tenure).


Board Members

Experienced Board: BHTG's board of directors are considered experienced (5.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.6%.


Top Shareholders

Company Information

BioHiTech Global, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: BioHiTech Global, Inc.
  • Ticker: BHTG
  • Exchange: NasdaqCM
  • Founded: NaN
  • Industry: Environmental and Facilities Services
  • Sector: Commercial Services
  • Market Cap: US$38.323m
  • Shares outstanding: 29.03m
  • Website: https://www.biohitech.com

Number of Employees


Location

  • BioHiTech Global, Inc.
  • 80 Red Schoolhouse Road
  • Suite 101
  • Chestnut Ridge
  • New York
  • 10977
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/19 23:50
End of Day Share Price2021/10/19 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.